Compared with the first time in 2016, this year, the Customer Gratitude Conference has been expanded by Cuu Long Pharmaceutical Joint Stock Company (DCL) in 11 provinces across the country, from Hai Phong – Hanoi – Nghe An – Da Nang to Khanh Hoa – Dak Lak – Saigon – Dong Nai – Can Tho – An Giang and finally Ca Mau. The conference was attended by 2,500 guests representing provincial leaders, distributors and customers in the provinces where the conference was held.

With the theme “For the health of the community”, the 2017 Customer Gratitude Conference expressed the desire of the Board of Directors and all employees of the company making efforts to bring Cuu Long Pharmaceutical’s products with quality, diversity and help improve the health of the Vietnamese.

 Not only being the gratitude event, the conference is also an opportunity for DCL leaders to communicate, listen to the heart, aspirations of the loyal customers as well as a chance for DCL to share development orientation, plans of the company in the near future. This affirms that DCL sees the customers not only as partners but also important companions in all of its activities. The trust of customers is the belief and motivation for DCL to continue to grow in the future.

At the conference, DCL introduced its new Panalgan product line, which is expected to bring a new, closer look to the consumers, thereby bringing the Panalgan brand as well as DCL to a new height, affirming its position in the Vietnamese market. DCL’s Panalgan lines are manufactured on a modern line imported from Canada and South Korea with better packaging, the quality of materials following United States Pharmacopoeia (USP) which has analgesic, antipyretic effects, treatment of pain, flu. Since the new look of Panalgan was launched, DCL has received positive feedback from customers, contributing to the company’s branding in the market.

The Customer Gratitude Conference has ended successfully with the satisfaction of the customers. DCL expects that in the future, the system of drugstores will be further expanded, contributing to bringing widely quality drugs to the consumers, at the same time, cooperates to develop with pharmacies and drugstores in the spirit of “For the health of the community”.

Since becoming a member of F.I.T Group, with the orientation from its parent company, Cuu Long Pharmaceutical has made strong changes in the quality of its operations from the implementation of large projects such as the start of the construction of the capsule plant III, the establishment of Benovas cancer drug company, which became the first cancer drug manufacturing company in Vietnam and so on to the signs of improvement in business results. In the coming time, as pharmaceutical continues to be a strategic sector in FIT’s investment structure, Cuu Long Pharmaceutical promises to make further strides towards reaching the top five pharmaceutical companies in Vietnam.